BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve 1. Audited Financial Results of the company for the Quarter as well as Year ended on 31st March, 2022 along with Auditors Report thereon. 2. Any other routine businesses with the permission of the chair. Further, in continuation to earlier disclosure dated 29th March, 2022, pursuant to Company's Code of Conduct, to regulate, monitor and report trading in Company's Securities by Insider framed under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, Trading window for dealing in the securities of the Company shall open after 48 hours of declaration of Audited Financial Results for all designated persons, their immediate relatives and all connected persons covered under the aforesaid code.